Company intelligence / Profile preview

Kilow

Riyadh, Saudi Arabiakilow.com ↗

Ownership: Private
Development stage: Commercial

Overview

Kilow has launched a science-backed weight loss program tailored to the Saudi population. The platform combines personalized nutrition, sleep and exercise coaching with at-home lab testing, real-time health tracking via wearables, home delivery of GLP‑1 medications when appropriate, and licensed medical consultations. Early results highlight strong engagement due to cultural adaptation and seamless integration of medical/pharmaceutical support with behavioral change tools. The company is preparing for regional expansion and further product development including AI-powered meal feedback and precision medicine modules.

Therapeutic areas: Metabolic DisordersEndocrinology
Modalities: Small molecule (GLP-1 medications)Digital therapeutic (lifestyle modification, coaching)Device integration (wearables for tracking)
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Kilow.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kilow.

Explore the full profile